Elevation Oncology Inc

NASDAQ:ELEV   3:57:25 PM EDT
10.09
+0.19 (+1.92%)
Earnings Announcements

Elevation Oncology Reports Second Quarter 2021 Financial Results

Published: 08/12/2021 22:16 GMT
Elevation Oncology Inc (ELEV) - Elevation Oncology Reports Second Quarter 2021 Financial Results.
Elevation Oncology Inc - As of June 30, 2021, Company Had Cash and Cash Equivalents Totaling $158.0 Million.
Elevation Oncology Inc - Qtrly Loss per Share $4.84.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.38

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.45

More details on our Analysts Page.